In the third part of our series on pre-exposure prophylaxis (PrEP), Daily Xtra looks at the controversy surrounding the HIV prevention drug. While many people are heralding a new chapter in the fight against HIV, others say it’s much too early to claim victory.
In the above video, Nicolas Kazamia speaks with Robert Grant, a senior researcher at the Gladstone Institutes; Alan McCord, from Project Inform; HIV/AIDS prevention workers Tim Ryan and Steve Gibson, from Magnet, a sexual health clinic in San Francisco; and Dale Gluth, the San Francisco Bay area director of the AIDS Healthcare Foundation.
In the series
Part 1: Can a pill a day keep HIV away?
Part 2: A condom-free future?